Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Gemcitabine and Cisplatin in Locally Advanced Bladder Cancer

NCT01801644 is registered in ClinicalTrials.gov with Barmherzige Brüder Vienna as lead sponsor.

NCT NCT01801644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01801644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Gemcitabine and Cisplatin in Locally Advanced Bladder Cancer
Lead sponsor
Barmherzige Brüder Vienna
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2007
Completion date
February 28, 2013
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer